![Top Quote](/images/red-top-quote.gif)
CMDBioscience, a computational biotechnology company focused on developing computational tools to enable peptide discovery announced today the release of CMDInventus, a proprietary and fully validated computational peptide discovery platform. This platform when combined with the CMD expertise is poised to revolutionize the field of novel peptide discovery.